跳至主要内容
临床试验/NCT07202572
NCT07202572进行中(未招募)不适用

Comparative Effects Of Virtual Reality Vs Sham VR On Fibromyalgia Impact: A Randomized Crossover Clinical Trial

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年9月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Mayo Clinic
入组人数
40
试验地点
1
主要终点
Change in Fibromyalgia Impact Questionnaire Revised (FIQR) Score After Sham vs. Active VR

研究概览

简要总结

The purpose of this study is to understand the therapeutic impact of VR on Fibromyalgia symptoms and potentially increase the scope of treatment options for patients suffering from Fibromyalgia.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Participants will be blinded to the intervention type. They will not be informed whether they are receiving the active intervention (TRIPP VR meditation) or the sham VR. Study staff administering the interventions will not be blinded due to the nature of the VR content and setup requirements.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged >18 years old
  • Diagnosis of fibromyalgia based on ACR 2016 criteria
  • Stable on current medications and non-pharmacologic treatments for 4 weeks
  • Ability and willingness to use a Meta Quest 3 VR headset Fluent in English
  • Provide informed consent

排除标准

  • History of seizures or conditions contraindicating VR use
  • Severe psychiatric illness (e.g., psychosis)
  • Cognitive impairment interfering with study participation
  • Participation in other interventional trials

研究组 & 干预措施

Sequence A (TRIPP VR to Sham VR)

Experimental

Participants in this arm will receive 2 weeks of TRIPP VR meditation followed by a 2-week washout period, then 2 weeks of sham VR.

干预措施: TRIPP VR Meditation (Device)

Sequence B (Sham VR to TRIPP VR)

Sham Comparator

Participants in this arm will receive 2 weeks of sham VR followed by a 2-week washout period, then 2 weeks of TRIPP VR meditation.

干预措施: Sham VR (Behavioral)

结局指标

主要结局

Change in Fibromyalgia Impact Questionnaire Revised (FIQR) Score After Sham vs. Active VR

时间窗: Baseline, Week 2, and Week 4

The primary outcome is the change in Fibromyalgia Impact Questionnaire Revised (FIQR) score from baseline to post-intervention, comparing scores after sham VR and after active TRIPP VR meditation. FIQR ranges from 0-100 and higher scores indicate higher impact of the condition, ie are worse. FIQR will be measured at baseline, week 2, and week 4. For Sequence A, the sham VR score is taken at week 4; for Sequence B, at week 2. For Sequence A, the active VR score is at week 2; for Sequence B, at week 4. The primary comparison will be the within-subject difference in FIQR change from baseline between sham and active VR periods.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Anushka Irani

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验